Structural, optical, and bioimaging characterization of carbon quantum dots solvothermally synthesized from o -phenylenediamine
Beilstein Journal of Nanotechnology · 30.01.2023 · 14 · 165-174
DOI: 10.3762/bjnano.14.17 ↗Kurz gefasst
Fachartikel in der Zeitschrift Beilstein Journal of Nanotechnology, online erschienen am 30.01.2023. Verfasst von Zoran M Marković und 9 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Nuclear Sciences "Vinča"-National Institute of the Republic of Serbia, P.O.B. 522, 11001 Belgrade, Serbia. Die Arbeit wurde bisher 32-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Science Fund of the Republic of Serbia, Ministarstvo Prosvete, Nauke i Tehnološkog Razvoja.
Abstract (Originalsprache)
Carbon quantum dots as a novel type of carbon nanomaterials have attracted the attention of many researchers because of their unique optical, antibacterial, and anticancer properties as well as their biocompatibility. In this study, for the first time, carbon quantum dots were prepared from o -phenylenediamine dissolved in toluene by a solvothermal route. Subsequently, the prepared carbon quantum dots were encapsulated into polyurethane films by a swelling–encapsulation–shrink method. Analyses of the results obtained by different characterization methods (AFM, TEM, EDS, FTIR, photoluminescence, and EPR) indicate the significant influence of the precursor on structural, chemical, and optical properties. Antibacterial and cytotoxicity tests showed that these dots did not have any antibacterial potential, because of the low extent of reactive oxygen species production, and showed low dark cytotoxicity. By investigating the cellular uptake, it was established that these dots penetrated the HeLa cells and could be used as probes for bioimaging.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Institute of Nuclear Sciences "Vinča"-National Institute of the Republic of Serbia, P.O.B. 522, 11001 Belgrade, Serbia.
- Polymer Institute, Slovak Academy of Sciences, Dubravska cesta 9, 84 541 Bratislava, Slovakia.
- J. Heyrovsky Institute of Physical Chemistry, Academy of Sciences of the Czech Republic, Dolejškova 3, 182 23, Praha 8, Czech Republic.
- Faculty of Agriculture, University of Belgrade, Nemanjina 6, 11080 Belgrade-Zemun, Serbia.
- Institute of Molecular Genetics and Genetic Engineering, University of Belgrade, Vojvode Stepe 444a, 11042 Belgrade 152, Serbia.
- University of Belgrade, Faculty of Biology, Studentski trg 16, 11000 Belgrade, Serbia.
ORCID-Profile: Zoran M Marković, Martin Danko, Dušan D Milivojević, Pavel Kubat, Marija M Mojsin, Milena J Stevanović, Biljana M Todorović Marković
Förderung
- Science Fund of the Republic of Serbia
- Ministarstvo Prosvete, Nauke i Tehnološkog Razvoja
Zitieren
APA
Marković, Z. M., Budimir, M. D., Danko, M., Milivojević, D. D., Kubat, P., Zmejkoski, D. Z., Pavlović, V. B., Mojsin, M. M., Stevanović, M. J., & Todorović Marković, B. M. (2023). Structural, optical, and bioimaging characterization of carbon quantum dots solvothermally synthesized from o -phenylenediamine. Beilstein Journal of Nanotechnology, 14, 165-174. https://doi.org/10.3762/bjnano.14.17
Vancouver
Marković ZM, Budimir MD, Danko M, Milivojević DD, Kubat P, Zmejkoski DZ, et al. Structural, optical, and bioimaging characterization of carbon quantum dots solvothermally synthesized from o -phenylenediamine. Beilstein Journal of Nanotechnology. 2023;14:165-174. doi:10.3762/bjnano.14.17
BibTeX
@article{Markovi2023,
author = {Marković, Zoran M and Budimir, Milica D and Danko, Martin and Milivojević, Dušan D and Kubat, Pavel and Zmejkoski, Danica Z and Pavlović, Vladimir B and Mojsin, Marija M and Stevanović, Milena J and Todorović Marković, Biljana M},
title = {Structural, optical, and bioimaging characterization of carbon quantum dots solvothermally synthesized from o -phenylenediamine},
journal = {Beilstein Journal of Nanotechnology},
year = {2023},
volume = {14},
pages = {165--174},
doi = {10.3762/bjnano.14.17}
}
EUVIMED